Government of India
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Udyog Bhawan
New Delhi
Notification No. 50/2015-2020 | Dated: 10th January, 2022
Subject: – Amendment in Export Policy of Enoxaparin (formulation and API) and Intra-Venous Immunoglobulin (IVIG) (formulation and API) – regarding
S.O. 93(E) In exercise of powers conferred by Section 3 read with Section 5 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy. 2015-20. the Central Government hereby makes the following amendment in Chapter 29 and 30 of Schedule 2 of the ITCHS Export policy 2018 related to export of Enoxaparin and Intra-Venous Immunoglobulin (IVIG):
| S.No | ITC HS Codes |
Description | Present Policy | Revised Policy |
| 207AE | Ex2942 Ex3001 Ex3002 |
Enoxaparin (Formulation and API) | Free | Restricted |
| 207 AF | Ex3002 | Intra-Venous Immunoglobulin (IVIG) (Formulation and API) |
Free | Restricted |
2. Effect of this Notification:
The export of Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) falling under the ITC (HS) Codes specified above or falling under any other HS Code has been put under restricted category, with immediate effect.
(Amit Yadav)
Director General of Foreign Trade
Ex-Officio Additional Secretary, Government of India
E-mail: dgft@nic.in
(Issued from File No. 01/91/180/021/AM22/EC/E-30431)
